Skip to content

Evolus EOLS Current portion of contingent royalty obligation payable to Evolus Founders

Current portion of contingent royalty obligation payable to Evolus Founders at other companies

Omeros logo
OmerosOMER
$19.86M-5.8%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$72M+25.5%
Acacia Research logo
Acacia ResearchACTG
$6.63M-75.2%
Abercrombie & Fitch logo
Abercrombie & FitchANF
$34.31M+3.8%
Gentex logo
GentexGNTX
$29.36M+39.2%
Cactus logo
CactusWHD
$21.31M+5.0%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept eols:ContingentRoyaltyObligationPayabletoRelatedPartyCurrent.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's current portion of contingent royalty obligation payable to evolus founders.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's current portion of contingent royalty obligation payable to evolus founders?
Evolus (EOLS) reported current portion of contingent royalty obligation payable to evolus founders of $12.76M in Q1 2026.
How has Evolus's current portion of contingent royalty obligation payable to evolus founders changed year-over-year?
Evolus's current portion of contingent royalty obligation payable to evolus founders increased by 11.3% year-over-year, from $11.47M to $12.76M.
What is the long-term trend for Evolus's current portion of contingent royalty obligation payable to evolus founders?
Over 5 years (2020 to 2025), Evolus's current portion of contingent royalty obligation payable to evolus founders has grown at a 29.4% compound annual growth rate (CAGR), from $3.45M to $12.52M.
What does current portion of contingent royalty obligation payable to evolus founders mean?
This represents the portion of royalty payments owed to company founders or related parties that is expected to be settled within the next twelve months. It reflects short-term cash outflows tied to the commercial success and revenue generation of the company's core product portfolio. Monitoring this liability is essential for assessing near-term liquidity requirements and the impact of founder-related compensation structures on operating cash flow.